Small Business Matters
HBW Insight’s coverage of news and issues impacting small and mid-sized enterprises.
Over The Counter 18 Mar 2024: How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen
In this episode, HBW Insight dives into personalized wellness with Marni Allen, chief marketing officer at tailored supplements manufacturer Bioniq. Named as one of EY UK's 50 Women to Watch in 2022, Allen has over 20 years’ experience in consumer healthcare, and is now working with Bioniq to create the next generation of bespoke wellness products for consumers across the world. As well as its top tier at-home blood test-based service, Bioniq also offers an affordable questionnaire-based option, which leverages the power of AI to analyse users’ nutritional needs and provide unique supplement formulations in the post. Although personalized wellness is still somewhat niche, Allen suggests that AI-based models like Bioniq offer an attractive option for traditional consumer health companies looking to get into this fast-growing market.
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
BetterYou Supports Struggling New UK Families With Baby Vitamins
Thousands of UK families will be supported with oral spray vitamins among other things thanks to an ongoing partnership between UK supplements manufacturer BetterYou and UK charity Baby Basics.
Maxwellia Adds STI Home-Test To UK Lovi Line
UK sexual health specialist Maxwellia continues to expand its UK footprint with an STI home-test launch under the Lovi brand umbrella.
ASA Files: How Not To Advertise A CBD Food Supplement In The UK
A recent ASA ruling against UK firm Supreme CBD highlights the need to be transparent about influencer marketing, as well as to avoid making any medicinal claims for food supplements.
German OTC Launches And Revitalizations From P&G, Stada, Théa and TheOTCLab
Botanical extracts power new products from P&G Health and Théa Pharmaceuticals in the areas of pain and eye-care respectively, while TheOTCLab and Stada relaunch much-loved foot care and cold brands in this German OTC marketing update.
Over The Counter 5 Feb 2024: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate
HBW Insight continues its conversation with The Exponential Club’s Nick Tate. In this episode, we discuss what the future of consumer health might actually look like, covering a lot of ground from nudge-based health insurance platforms to digital products that may supplement or even replace traditional drugs. We also talk about the promise and limitations of at-home testing for furthering personalization, and how to navigate partnerships with tech-specialists large and small to help accelerate digital transformation plans.
Clasado Prebiotic Real-World Evidence Study Suggests Positive Impact On IBS, Pain And Sleep
Individuals using Clasado Biosciences' Bimuno GOS prebiotic for gastrointestinal problems, chronic pain and sleep reported a “marked self-reported improvement in quality of life,” according to a recently-published real-world evidence study.
UK’s Dexcel Pharma Snaps Up Eight OTC Brands From Teva
Dexcel Pharma has acquired eight OTC brands from Teva, including Bisodol Indigestion Relief Tablets, erectile dysfunction treatment Liberize and Yeast Vite supplements. Teva told HBW Insight it remains committed to the consumer health market despite a number of recent brand divestments.
Futura Extends Europe Licensing Agreement With Cooper For Eroxon ED Gel
Futura Medical has extended its licensing agreement with Cooper Consumer Health for the rights to market its Eroxon topical, gel-based erectile dysfunction treatment throughout the European Economic Area, United Kingdom and Switzerland until 2029.
Get To Know: ‘Medicine Cabinet Staples’ Manufacturer Kobayashi Healthcare Europe
Manufacturing best-selling items like Kool 'n' Soothe cooling sheet, Cura-Heat heat pack and Hothands hand warmer brands in its own facilities means Kobayashi Healthcare Europe can offer “great quality products without breaking the bank,” explains marketing and regulatory manager Richard Noal.
German OTC Launches: Bayer Adds Probiotics, Angelini Expands ThermaCare, And More
Two microbiome products added to Bayer's Iberogast line, a new drug-free pain-relieving ThermaCare knee brace from Angelini Pharma and an ashwagandha-powered sleep aid extension to Oyono from Klosterfrau feature in this German marketing update.
Female Sexual Dysfunction, China, Next On The Agenda For Eroxon Creator Futura
Drug-free erectile dysfunction “stimgel” creator Futura wants to see if the technology underpinning Eroxon can be applied to female sexual dysfunction. Breaking into China is also high up on the agenda for the UK-based R&D company's CEO James Barder, he reveals in this exclusive interview.
UK Health Food Chain Reinstates CBD Products After FSA-Related Review
The UK's largest health food chain Holland & Barrett has reinstated over 30 CBD products after initially removing them from shelves in response to the FSA's recommendation that consumers should only take 10mg CBD a day.
Get To Know: Tally Health Clocks Epigenome, Lifestyle Factors For Healthier Aging
Startup aims to improve health span and extend longevity at the cellular level with TallyAge epigenetic age tests, personalized lifestyle recommendations and longevity supplements.
Get To Know: Irish Iron Specialist Solvotrin Therapeutics
Irish firm Solvotrin Therapeutics markets its Active Iron supplement brand across 14 international markets including the UK, US and China.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.